PROCEPT BioRobotics Corporation (PRCT) Gains 40% Following Strong Q3 Earnings and Upgraded Guidance - InvestingChannel

PROCEPT BioRobotics Corporation (PRCT) Gains 40% Following Strong Q3 Earnings and Upgraded Guidance

We recently compiled a list of the 10 Emerging AI Stocks that Outperformed the Broader Market This Month. In this article, we are going to take a look at where PROCEPT BioRobotics Corporation (NASDAQ:PRCT) stands against the other emerging AI stocks.

In an interview with CNBC on November 25, Dan Ives, Global Head of Technology Research at Wedbush Securities said that he sees the AI sector entering a new phase, describing it as the start of a “fourth industrial revolution.” He believes the AI market is still in its early stages but will continue to grow rapidly. Ives highlighted software companies, which he believes will be key players in AI’s future, especially by 2025.

Apart from a handful of skeptics, most experts and analysts see AI as the most revolutionary technology of the 21st century. There has also been a rise in AI startups. According to a June report by Morgan Stanley, the tech IPO market is picking up after a two-year pause. High interest rates had previously dampened IPO activity, but demand is returning, especially for companies using AI to improve business operations or customer experiences. While challenges like high capital costs remain, the AI-driven growth in tech and healthcare sectors is fueling the IPO revival.

Read Also: 15 AI Stocks on Wall Street’s Radar and Jim Cramer’s List of 7 Energy Stocks for the Trump Trade.

Anticipating the Next Wave of Startup IPOs

One of the most promising startups the market is watching is Anthropic AI, an AI company focused on developing safe and reliable large language models. It has received funding from big names, including Amazon. The partnership designates AWS as Anthropic’s primary cloud and training partner, with a focus on improving AI capabilities through collaboration on machine learning hardware development.

Additionally, AI chipmaker Cerebras is seeking to go public with a valuation of around $7 to $8 billion, building on strong AI infrastructure demand. The firm filed for an IPO on September 30. MS expects 10 to 15 tech IPOs in 2024, driven by companies using AI in sectors like technology and healthcare.

Read more about these developments by accessing 30 Most Important AI Stocks According to BlackRock and Beyond the Tech Giants: 35 Non-Tech AI Opportunities.

For this article, we chose 10 AI stocks that have outperformed the S&P 500 over the last 30 days as of November 27. They are also popular among hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

A medical technician using surgical robotics to perform minimally-invasive urologic surgery in an operating room.

PROCEPT BioRobotics Corporation (NASDAQ:PRCT)

30-day Stock Price Performance: 7%

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) specializes in surgical robotics for urology, offering the AquaBeam Robotic System and Aquablation therapy for treating benign prostatic hyperplasia (BPH). The company’s AI-driven solutions provide image-guided, minimally invasive procedures to improve patient outcomes in urologic surgery.

While PROCEPT’s (NASDAQ:PRCT) stock has seen quite a bit of volatility over the last 30 days, its stock performance got a significant boost after a strong earnings report on October 28 and the stock has been up over 40% since the announcement.

After the earnings, TipRanks reported that Josh Jennings from TD Cowen maintained a Buy rating on the company stock with a $99 price target, owing to strong third-quarter results driven by higher system and consumable sales. The company showed solid growth in both U.S. and international markets, especially in the UK, and improved its financial outlook. The positive revision in guidance, increased gross margin, and reduced net loss contributed to Jennings’s favorable view of PROCEPT’s (NASDAQ:PRCT) future performance.

Overall PRCT ranks 10th on our list of the emerging AI stocks that outperformed the broader market this month. While we acknowledge the potential of PRCT as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than PRCT but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

 

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

 

Disclosure: None. This article is originally published at Insider Monkey.

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire